NCH Rooney Heart Institute Leads Successful Clinical Trial for Groundbreaking Cardiac Ablation Technology
The NCH Rooney Heart Institute has successfully completed a clinical trial of the Affera™ Mapping and Ablation System featuring the Sphere-9™ Catheter, a next-generation technology designed to enhance the treatment of atrial fibrillation (AF) and other complex cardiac arrhythmias. NCH is one of only two sites in the state offering this groundbreaking technology. The trial, led by Dinesh Sharma, MD, demonstrated the system’s safety and effectiveness, marking a significant advancement in electrophysiology care.
Affera’s innovative platform integrates high-density mapping with dual-energy ablation capabilities, offering both pulsed field (PF) and radiofrequency (RF) energies. This dual-energy approach allows for more precise, patient-specific treatment, improving outcomes and procedural efficiency…